285. ファンコニ貧血 Fanconi anemia Clinical trials / Disease details

臨床試験数 : 62 / 薬物数 : 93 - (DrugBank : 30) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 144

10 trials found

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03579875 (ClinicalTrials.gov)	November 13, 2018	25/5/2018	T Cell Receptor a/ß TCD HCT in Patients With Fanconi Anemia	T Cell Receptor Alpha/Beta T Cell Depleted (a/ß TCD) Hematopoietic Cell Transplantation in Patients ...	Fanconi Anemia;Severe Aplastic Anemia;Myelodysplastic Syndromes	Drug: Total Body Irradiation (TBI) (Plan 1);Drug: Cyclophosphamide (CY) (Plan 1);Drug: Fludarabine (FL ...	Masonic Cancer Center, University of Minnesota	NULL	Recruiting	N/A	65 Years	All	48	Phase 2	United States
2	NCT03600909 (ClinicalTrials.gov)	May 15, 2018	17/7/2018	A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fancon ...	A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanco ...	Fanconi Anemia;Myelodysplastic Syndrome (MDS);Acute Myelogenous Leukemia (AML)	Drug: Busulfan;Drug: Fludarabine;Drug: Cyclophosphamide;Drug: Anti-Thymocyte Globulin (Rabbit);Devic ...	Memorial Sloan Kettering Cancer Center	Pediatric Brain Tumor Consortium	Completed	1 Month	N/A	All	3	Phase 2	United States
3	NCT02143830 (ClinicalTrials.gov)	April 2014	28/4/2014	HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy	A Phase II Trial of HSCT for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically I ...	Fanconi Anemia;Severe Marrow Failure;Myelodysplastic Syndrome (MDS);Acute Myelogenous Leukemia (AML) ...	Drug: Busulfan;Drug: Cyclophosphamide;Drug: Fludarabine;Drug: rabbit ATG;Drug: G-CSF;Biological: Peri ...	Children's Hospital Medical Center, Cincinnati	Fred Hutchinson Cancer Center;Memorial Sloan Kettering Cancer Center	Recruiting	3 Months	N/A	All	70	Phase 2	United States
4	NCT01082133 (ClinicalTrials.gov)	October 2009	5/3/2010	Multicenter Transplant Study for Fanconi Anemia	A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patient ...	Fanconi Anemia	Drug: Chemotherapy;Biological: Miltenyi CliniMACS	Children's Hospital Medical Center, Cincinnati	NULL	Completed	N/A	N/A	Both	45	Phase 2	United States
5	NCT00987480 (ClinicalTrials.gov)	September 25, 2009	30/9/2009	Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a ...	A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patient ...	Aplastic Anemia;Leukemia;Myelodysplastic Syndrome	Drug: Busulfan , fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.;De ...	Memorial Sloan Kettering Cancer Center	Boston Children's Hospital;Children's Hospital Medical Center, Cincinnati;Children's Hospital and He ...	Completed	N/A	N/A	All	45	Phase 2	United States
6	NCT01071239 (ClinicalTrials.gov)	April 2009	20/5/2009	Hematopoietic Stem Cell Transplant for Fanconi Anemia	A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanco ...	Fanconi Anemia	Device: CliniMACs device;Drug: Busulfan;Drug: Fludarabine;Drug: Cyclophosphamide;Drug: ATG	Medical College of Wisconsin	Memorial Sloan Kettering Cancer Center	Completed	N/A	N/A	All	1	Phase 2	United States
7	NCT00084695 (ClinicalTrials.gov)	September 2003	10/6/2004	Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonm ...	The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells	Childhood Langerhans Cell Histiocytosis;Fanconi Anemia;Leukemia;Lymphoma;Myelodysplastic Syndromes;N ...	Biological: anti-thymocyte globulin;Drug: busulfan;Drug: cyclophosphamide;Drug: fludarabine phosphate ...	Milton S. Hershey Medical Center	NULL	Recruiting	N/A	21 Years	Both	25	Phase 2	United States
8	NCT00258427 (ClinicalTrials.gov)	March 26, 2002	22/11/2005	Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia	Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02	Fanconi Anemia	Biological: anti-thymocyte globulin;Biological: filgrastim;Drug: busulfan;Drug: cyclophosphamide;Dru ...	Masonic Cancer Center, University of Minnesota	NULL	Completed	N/A	44 Years	All	14	Phase 2	United States
9	NCT00305708 (ClinicalTrials.gov)	August 2000	21/3/2006	Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treati ...	Bone Marrow Stem Cell Transplantation for Children With Stem Cell Defects, Marrow Failure Syndromes, ...	Congenital Amegakaryocytic Thrombocytopenia;Diamond-blackfan Anemia;Fanconi Anemia;Leukemia;Severe C ...	Biological: anti-thymocyte globulin;Drug: busulfan;Drug: fludarabine phosphate;Procedure: allogeneic ...	University of California, San Francisco	National Cancer Institute (NCI)	Completed	N/A	17 Years	Both	40	Phase 1/Phase 2	United States
10	NCT00290628 (ClinicalTrials.gov)	October 1999	9/2/2006	Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer	Transplantation of Umbilical Cord Blood From Related and Unrelated Donors	Chronic Myeloproliferative Disorders;Diamond-blackfan Anemia;Fanconi Anemia;Graft Versus Host Diseas ...	Drug: cyclophosphamide;Drug: cyclosporine;Drug: filgrastim;Drug: melphalan;Drug: methylprednisolone; ...	Masonic Cancer Center, University of Minnesota	National Cancer Institute (NCI)	Terminated	N/A	45 Years	All	43	N/A	United States

First Previous1Next Last